Skip to main content

Herbert Kim Lyerly, MD

George Barth Geller Professor
Campus Mail: 203 Research Drive, Rm 433B, Box 2606, Durham, NC 27710
Phone: (919) 681-8350
Email: lyerl001@mc.duke.edu

Education and Training

  • M.D., University of California at Los Angeles, 1983

Selected Grants and Awards

Selected Publications

Morse, Michael A., Smita K. Nair, Paul J. Mosca, Amy C. Hobeika, Timothy M. Clay, Yuping Deng, David Boczkowski, et al. “Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA..” Cancer Invest 21, no. 3 (June 2003): 341–49. https://doi.org/10.1081/cnv-120018224.

Full Text

Morse, Michael A., Timothy M. Clay, Kirsten Colling, Amy Hobeika, Ken Grabstein, Martin A. Cheever, and H Kim Lyerly. “HER2 dendritic cell vaccines..” Clin Breast Cancer 3 Suppl 4 (February 2003): S164–72.

Scholars@Duke

Mosca, Paul J., Amy C. Hobeika, Kirsten Colling, Timothy M. Clay, Elaine K. Thomas, Dania Caron, H Kim Lyerly, and Michael A. Morse. “Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand..” J Leukoc Biol 72, no. 3 (September 2002): 546–53.

Scholars@Duke

Morse, Michael A., David Rizzieri, Timothy T. Stenzel, Amy C. Hobeika, James J. Vredenburgh, Nelson J. Chao, Timothy M. Clay, Paul J. Mosca, and H Kim Lyerly. “Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants..” J Hematother Stem Cell Res 11, no. 4 (August 2002): 659–68. https://doi.org/10.1089/15258160260194802.

Full Text

Keilholz, Ulrich, Jeffrey Weber, James H. Finke, Dmitry I. Gabrilovich, W Martin Kast, Mary L. Disis, John M. Kirkwood, et al. “Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy..” J Immunother 25, no. 2 (March 2002): 97–138.

Scholars@Duke

Morse, Michael A., Smita K. Nair, David Boczkowski, Douglas Tyler, Herbert I. Hurwitz, Alan Proia, Timothy M. Clay, Jeffrey Schlom, Eli Gilboa, and H Kim Lyerly. “The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer..” Int J Gastrointest Cancer 32, no. 1 (2002): 1–6. https://doi.org/10.1385/IJGC:32:1:1.

Full Text

Morse, M. A., S. Nair, M. Fernandez-Casal, Y. Deng, M. St Peter, R. Williams, A. Hobeika, et al. “Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer..” J Clin Oncol 18, no. 23 (December 1, 2000): 3883–93. https://doi.org/10.1200/JCO.2000.18.23.3883.

Full Text

Mosca, P. J., A. C. Hobeika, T. M. Clay, S. K. Nair, E. K. Thomas, M. A. Morse, and H. K. Lyerly. “A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment..” Blood 96, no. 10 (November 15, 2000): 3499–3504.

Scholars@Duke

Li, Y., M. Bendandi, Y. Deng, C. Dunbar, N. Munshi, S. Jagannath, L. W. Kwak, and H. K. Lyerly. “Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells..” Blood 96, no. 8 (October 15, 2000): 2828–33.

Scholars@Duke

Markert, M. L., C. B. Hicks, J. A. Bartlett, J. L. Harmon, L. P. Hale, M. L. Greenberg, G. Ferrari, et al. “Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection..” Aids Res Hum Retroviruses 16, no. 5 (March 20, 2000): 403–13. https://doi.org/10.1089/088922200309061.

Full Text

Boczkowski, D., S. K. Nair, J. H. Nam, H. K. Lyerly, and E. Gilboa. “Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells..” Cancer Res 60, no. 4 (February 15, 2000): 1028–34.

Scholars@Duke

Pages